Symbol:
Slc25a37
Name:
solute carrier family 25 member 37
RGD ID:
1359361
Description:
Predicted to enable ferrous iron transmembrane transporter activity. Predicted to be involved in iron import into the mitochondrion and positive regulation of hemoglobin biosynthetic process. Predicted to be located in mitochondrial inner membrane. Predicted to be active in mitochondrial membrane. Orthologous to human SLC25A37 (solute carrier family 25 member 37); PARTICIPATES IN iron uptake pathway; INTERACTS WITH 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
LOC306000; mitochondrial carrier domain containing protein RGD1359361; mitochondrial iron transporter 1; mitochondrial solute carrier-like protein; mitoferrin-1; Mscp; RGD1359361; similar to mitochondrial solute carrier-like protein; solute carrier family 25 (mitochondrial iron transporter), member 37; solute carrier family 25, member 37
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
SLC25A37 (solute carrier family 25 member 37)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Slc25a37 (solute carrier family 25, member 37)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Slc25a37 (solute carrier family 25 member 37)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
SLC25A37 (solute carrier family 25 member 37)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
SLC25A37 (solute carrier family 25 member 37)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Slc25a37 (solute carrier family 25 member 37)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
SLC25A37 (solute carrier family 25 member 37)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
SLC25A37 (solute carrier family 25 member 37)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Slc25a37 (solute carrier family 25 member 37)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Mus musculus (house mouse):
Slc25a37 (solute carrier family 25, member 37)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
SLC25A37 (solute carrier family 25 member 37)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
slc25a37 (solute carrier family 25 member 37)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
MRS3
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
mfn-1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|SonicParanoid)
Drosophila melanogaster (fruit fly):
mfrn
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PhylomeDB|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
MRS4
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
slc25a37
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 15 50,944,085 - 50,986,506 (-) NCBI GRCr8 mRatBN7.2 15 44,534,280 - 44,576,697 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 15 44,536,727 - 44,577,199 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 15 48,654,708 - 48,694,617 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 15 49,766,201 - 49,806,109 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 15 46,625,537 - 46,665,442 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 15 51,125,764 - 51,168,384 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 15 51,128,268 - 51,168,384 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 15 54,858,085 - 54,898,295 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 15 49,806,324 - 49,846,988 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 15 49,822,103 - 49,862,768 (-) NCBI Celera 15 44,219,968 - 44,259,652 (-) NCBI Celera Cytogenetic Map 15 p11 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Slc25a37 Rat (-)-demecolcine decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Demecolcine results in decreased expression of SLC25A37 mRNA CTD PMID:23649840 Slc25a37 Rat (1->4)-beta-D-glucan multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC25A37 mRNA CTD PMID:36331819 Slc25a37 Rat 1,2-dimethylhydrazine multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A37 mRNA CTD PMID:22206623 Slc25a37 Rat 1,2-dimethylhydrazine affects expression ISO Slc25a37 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of SLC25A37 mRNA CTD PMID:22206623 Slc25a37 Rat 17alpha-ethynylestradiol affects expression ISO Slc25a37 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of SLC25A37 mRNA CTD PMID:17555576 Slc25a37 Rat 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC25A37 mRNA CTD PMID:26496021 Slc25a37 Rat 17beta-estradiol multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of SLC25A37 mRNA CTD PMID:30165855 Slc25a37 Rat 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO SLC25A37 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of SLC25A37 mRNA CTD PMID:29581250 Slc25a37 Rat 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [Flame Retardants results in increased abundance of 2 more ... CTD PMID:38995820 Slc25a37 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc25a37 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC25A37 mRNA CTD PMID:19770486 and PMID:29673856 Slc25a37 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Slc25a37 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC25A37 mRNA CTD PMID:28213091 Slc25a37 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc25a37 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC25A37 mRNA CTD PMID:21570461 Slc25a37 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC25A37 mRNA CTD PMID:21215274 Slc25a37 Rat 2-butoxyethanol increases expression ISO Slc25a37 (Mus musculus) 6480464 n-butoxyethanol results in increased expression of SLC25A37 mRNA CTD PMID:19812364 Slc25a37 Rat 2-palmitoylglycerol increases expression ISO SLC25A37 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of SLC25A37 mRNA CTD PMID:37199045 Slc25a37 Rat 3,3',5,5'-tetrabromobisphenol A increases expression ISO Slc25a37 (Mus musculus) 6480464 tetrabromobisphenol A results in increased expression of SLC25A37 mRNA CTD PMID:25172293 Slc25a37 Rat 3,4-methylenedioxymethamphetamine increases expression ISO Slc25a37 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SLC25A37 mRNA CTD PMID:20188158 Slc25a37 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC25A37 mRNA CTD PMID:24780913 Slc25a37 Rat acrolein multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC25A37 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SLC25A37 mRNA CTD PMID:32699268 Slc25a37 Rat aflatoxin B1 increases methylation ISO SLC25A37 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of SLC25A37 gene and Aflatoxin B1 results in increased methylation of SLC25A37 intron CTD PMID:28458013 and PMID:30157460 Slc25a37 Rat Aflatoxin B2 alpha increases methylation ISO SLC25A37 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of SLC25A37 intron CTD PMID:30157460 Slc25a37 Rat all-trans-retinoic acid increases expression ISO SLC25A37 (Homo sapiens) 6480464 Tretinoin results in increased expression of SLC25A37 mRNA CTD PMID:17218384 Slc25a37 Rat alpha-pinene multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC25A37 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SLC25A37 mRNA CTD PMID:32699268 Slc25a37 Rat anthracen-2-amine increases expression EXP 6480464 2-anthramine results in increased expression of SLC25A37 mRNA CTD PMID:23038007 Slc25a37 Rat aristolochic acid A decreases expression ISO SLC25A37 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of SLC25A37 mRNA CTD PMID:33212167 Slc25a37 Rat arsenous acid multiple interactions ISO Slc25a37 (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of SLC25A37 mRNA] CTD PMID:29095437 Slc25a37 Rat arsenous acid decreases expression ISO Slc25a37 (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of SLC25A37 mRNA CTD PMID:29095437 Slc25a37 Rat atrazine increases expression ISO SLC25A37 (Homo sapiens) 6480464 Atrazine results in increased expression of SLC25A37 mRNA CTD PMID:22378314 Slc25a37 Rat avobenzone increases expression ISO SLC25A37 (Homo sapiens) 6480464 avobenzone results in increased expression of SLC25A37 mRNA CTD PMID:31016361 Slc25a37 Rat benzo[a]pyrene decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC25A37 mRNA CTD PMID:26238291 and PMID:30453624 Slc25a37 Rat benzo[a]pyrene multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Ethanol co-treated with Benzo(a)pyrene] results in increased expression of SLC25A37 mRNA CTD PMID:35412187 Slc25a37 Rat benzo[a]pyrene affects methylation ISO SLC25A37 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC25A37 promoter CTD PMID:27901495 Slc25a37 Rat benzo[a]pyrene diol epoxide I decreases expression ISO SLC25A37 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20018196 Slc25a37 Rat benzo[e]pyrene increases methylation ISO SLC25A37 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of SLC25A37 intron CTD PMID:30157460 Slc25a37 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC25A37 mRNA and [bisphenol A co-treated with Testosterone] results in increased expression of SLC25A37 mRNA CTD PMID:26496021 Slc25a37 Rat bisphenol A decreases expression ISO Slc25a37 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC25A37 mRNA CTD PMID:32156529 Slc25a37 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC25A37 mRNA CTD PMID:32145629 Slc25a37 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC25A37 mRNA CTD PMID:25181051 Slc25a37 Rat caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of SLC25A37 mRNA CTD PMID:20864626 Slc25a37 Rat carbon nanotube decreases expression ISO Slc25a37 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 Slc25a37 Rat cobalt dichloride increases expression ISO SLC25A37 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of SLC25A37 mRNA CTD PMID:19376846 Slc25a37 Rat cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of SLC25A37 mRNA CTD PMID:24386269 Slc25a37 Rat cocaine increases expression ISO SLC25A37 (Homo sapiens) 6480464 Cocaine results in increased expression of SLC25A37 mRNA CTD PMID:15009677 and PMID:16710320 Slc25a37 Rat copper atom multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC25A37 mRNA CTD PMID:24690739 Slc25a37 Rat copper(0) multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC25A37 mRNA CTD PMID:24690739 Slc25a37 Rat copper(II) sulfate increases expression ISO SLC25A37 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of SLC25A37 mRNA CTD PMID:19549813 Slc25a37 Rat coumarin increases phosphorylation ISO SLC25A37 (Homo sapiens) 6480464 coumarin results in increased phosphorylation of SLC25A37 protein CTD PMID:35688186 Slc25a37 Rat coumestrol decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Coumestrol results in decreased expression of SLC25A37 mRNA CTD PMID:19167446 Slc25a37 Rat crocidolite asbestos affects expression ISO SLC25A37 (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of SLC25A37 mRNA CTD PMID:24160326 Slc25a37 Rat crocidolite asbestos decreases expression ISO Slc25a37 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of SLC25A37 mRNA CTD PMID:29279043 Slc25a37 Rat crocidolite asbestos decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of SLC25A37 mRNA CTD PMID:29523930 Slc25a37 Rat cyclosporin A decreases expression ISO Slc25a37 (Mus musculus) 6480464 Cyclosporine results in decreased expression of SLC25A37 mRNA CTD PMID:19770486 Slc25a37 Rat cyclosporin A increases expression ISO SLC25A37 (Homo sapiens) 6480464 Cyclosporine results in increased expression of SLC25A37 mRNA CTD PMID:25562108 Slc25a37 Rat cyproconazole increases expression ISO Slc25a37 (Mus musculus) 6480464 cyproconazole results in increased expression of SLC25A37 mRNA CTD PMID:22334560 Slc25a37 Rat diarsenic trioxide multiple interactions ISO Slc25a37 (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of SLC25A37 mRNA] CTD PMID:29095437 Slc25a37 Rat diarsenic trioxide decreases expression ISO Slc25a37 (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of SLC25A37 mRNA CTD PMID:29095437 Slc25a37 Rat dibenz[a,h]anthracene decreases expression ISO Slc25a37 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 Slc25a37 Rat Dibutyl phosphate affects expression ISO SLC25A37 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of SLC25A37 mRNA CTD PMID:37042841 Slc25a37 Rat dibutyl phthalate increases expression ISO Slc25a37 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of SLC25A37 mRNA CTD PMID:21266533 Slc25a37 Rat disulfiram multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC25A37 mRNA CTD PMID:24690739 Slc25a37 Rat dorsomorphin multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A37 mRNA CTD PMID:27188386 Slc25a37 Rat elemental selenium increases expression ISO SLC25A37 (Homo sapiens) 6480464 Selenium results in increased expression of SLC25A37 mRNA CTD PMID:19244175 Slc25a37 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SLC25A37 mRNA CTD PMID:29391264 Slc25a37 Rat entinostat multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A37 mRNA CTD PMID:27188386 Slc25a37 Rat entinostat decreases expression ISO SLC25A37 (Homo sapiens) 6480464 entinostat results in decreased expression of SLC25A37 mRNA CTD PMID:26272509 Slc25a37 Rat epoxiconazole increases expression ISO Slc25a37 (Mus musculus) 6480464 epoxiconazole results in increased expression of SLC25A37 mRNA CTD PMID:22334560 Slc25a37 Rat epoxiconazole affects expression ISO Slc25a37 (Mus musculus) 6480464 epoxiconazole affects the expression of SLC25A37 mRNA CTD PMID:35436446 Slc25a37 Rat ethanol multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Ethanol co-treated with Benzo(a)pyrene] results in increased expression of SLC25A37 mRNA CTD PMID:35412187 Slc25a37 Rat ethyl methanesulfonate decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of SLC25A37 mRNA CTD PMID:23649840 Slc25a37 Rat fluoranthene multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC25A37 mRNA CTD PMID:28329830 Slc25a37 Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of SLC25A37 mRNA CTD PMID:24136188 Slc25a37 Rat folic acid multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A37 mRNA CTD PMID:22206623 Slc25a37 Rat folic acid increases expression ISO Slc25a37 (Mus musculus) 6480464 Folic Acid results in increased expression of SLC25A37 mRNA CTD PMID:25629700 Slc25a37 Rat FR900359 affects phosphorylation ISO SLC25A37 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of SLC25A37 protein CTD PMID:37730182 Slc25a37 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC25A37 mRNA CTD PMID:33387578 Slc25a37 Rat heroin increases expression ISO SLC25A37 (Homo sapiens) 6480464 Heroin results in increased expression of SLC25A37 mRNA CTD PMID:16710320 Slc25a37 Rat inulin multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC25A37 mRNA CTD PMID:36331819 Slc25a37 Rat manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of SLC25A37 mRNA CTD PMID:28801915 Slc25a37 Rat metformin multiple interactions ISO Slc25a37 (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of SLC25A37 mRNA] CTD PMID:29095437 Slc25a37 Rat methapyrilene increases methylation ISO SLC25A37 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of SLC25A37 intron CTD PMID:30157460 Slc25a37 Rat methoxyacetic acid decreases expression EXP 6480464 methoxyacetic acid results in decreased expression of SLC25A37 mRNA CTD PMID:20864626 Slc25a37 Rat methyl methanesulfonate decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of SLC25A37 mRNA CTD PMID:23649840 Slc25a37 Rat methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of SLC25A37 mRNA CTD PMID:20864626 Slc25a37 Rat Monobutylphthalate decreases expression EXP 6480464 monobutyl phthalate results in decreased expression of SLC25A37 mRNA CTD PMID:20864626 Slc25a37 Rat N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC25A37 mRNA CTD PMID:28801915 Slc25a37 Rat nitrofen increases expression EXP 6480464 nitrofen results in increased expression of SLC25A37 mRNA CTD PMID:33484710 Slc25a37 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC25A37 mRNA CTD PMID:25729387 Slc25a37 Rat oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of SLC25A37 mRNA CTD PMID:25729387 Slc25a37 Rat ozone multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC25A37 mRNA more ... CTD PMID:32699268 Slc25a37 Rat ozone multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SLC25A37 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SLC25A37 mRNA CTD PMID:34911549 Slc25a37 Rat paracetamol decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC25A37 mRNA CTD PMID:21420995 Slc25a37 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Slc25a37 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC25A37 mRNA more ... CTD PMID:36331819 Slc25a37 Rat phenobarbital increases expression ISO Slc25a37 (Mus musculus) 6480464 Phenobarbital results in increased expression of SLC25A37 mRNA CTD PMID:19270015 Slc25a37 Rat phenobarbital affects expression ISO Slc25a37 (Mus musculus) 6480464 Phenobarbital affects the expression of SLC25A37 mRNA CTD PMID:23091169 Slc25a37 Rat phosphane increases expression EXP 6480464 phosphine results in increased expression of SLC25A37 mRNA CTD PMID:34427094 Slc25a37 Rat pirinixic acid multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC25A37 mRNA CTD PMID:19710929 Slc25a37 Rat pirinixic acid increases expression ISO Slc25a37 (Mus musculus) 6480464 pirinixic acid results in increased expression of SLC25A37 mRNA CTD PMID:18301758 Slc25a37 Rat pirinixic acid decreases expression ISO Slc25a37 (Mus musculus) 6480464 pirinixic acid results in decreased expression of SLC25A37 mRNA CTD PMID:18445702 Slc25a37 Rat potassium chromate decreases expression ISO SLC25A37 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of SLC25A37 mRNA CTD PMID:22714537 Slc25a37 Rat pregnenolone 16alpha-carbonitrile increases expression ISO Slc25a37 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of SLC25A37 mRNA CTD PMID:28903501 Slc25a37 Rat propiconazole increases expression ISO Slc25a37 (Mus musculus) 6480464 propiconazole results in increased expression of SLC25A37 mRNA CTD PMID:21278054 and PMID:22334560 Slc25a37 Rat resveratrol increases expression ISO Slc25a37 (Mus musculus) 6480464 resveratrol results in increased expression of SLC25A37 mRNA CTD PMID:22610192 Slc25a37 Rat rotenone increases expression ISO SLC25A37 (Homo sapiens) 6480464 Rotenone results in increased expression of SLC25A37 mRNA CTD PMID:29955902 Slc25a37 Rat SB 431542 multiple interactions ISO SLC25A37 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A37 mRNA CTD PMID:27188386 Slc25a37 Rat selenium atom increases expression ISO SLC25A37 (Homo sapiens) 6480464 Selenium results in increased expression of SLC25A37 mRNA CTD PMID:19244175 Slc25a37 Rat serpentine asbestos affects expression ISO SLC25A37 (Homo sapiens) 6480464 Asbestos and Serpentine affects the expression of SLC25A37 mRNA CTD PMID:24160326 Slc25a37 Rat silicon dioxide decreases expression ISO Slc25a37 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of SLC25A37 mRNA CTD PMID:19073995 Slc25a37 Rat sodium arsenite decreases expression ISO SLC25A37 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SLC25A37 mRNA CTD PMID:22714537 and PMID:38568856 Slc25a37 Rat sodium arsenite affects expression ISO SLC25A37 (Homo sapiens) 6480464 sodium arsenite affects the expression of SLC25A37 mRNA CTD PMID:29319823 Slc25a37 Rat sunitinib increases expression ISO SLC25A37 (Homo sapiens) 6480464 Sunitinib results in increased expression of SLC25A37 mRNA CTD PMID:31533062 Slc25a37 Rat tamoxifen affects expression ISO Slc25a37 (Mus musculus) 6480464 Tamoxifen affects the expression of SLC25A37 mRNA CTD PMID:17555576 Slc25a37 Rat tamoxifen increases expression ISO Slc25a37 (Mus musculus) 6480464 Tamoxifen results in increased expression of SLC25A37 mRNA CTD PMID:17555576 Slc25a37 Rat testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of SLC25A37 mRNA CTD PMID:26496021 Slc25a37 Rat tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SLC25A37 mRNA CTD PMID:31150632 Slc25a37 Rat tetrachloromethane increases expression ISO Slc25a37 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of SLC25A37 mRNA CTD PMID:31919559 Slc25a37 Rat titanium dioxide decreases methylation ISO Slc25a37 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of SLC25A37 gene CTD PMID:35295148 Slc25a37 Rat titanium dioxide increases expression ISO Slc25a37 (Mus musculus) 6480464 titanium dioxide results in increased expression of SLC25A37 mRNA CTD PMID:23557971 more ... Slc25a37 Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of SLC25A37 mRNA CTD PMID:25729387 Slc25a37 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC25A37 mRNA CTD PMID:25729387 Slc25a37 Rat trimellitic anhydride increases expression ISO Slc25a37 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of SLC25A37 mRNA CTD PMID:19042947 Slc25a37 Rat triphenyl phosphate affects expression ISO SLC25A37 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of SLC25A37 mRNA CTD PMID:37042841 Slc25a37 Rat tungsten decreases expression ISO Slc25a37 (Mus musculus) 6480464 Tungsten results in decreased expression of SLC25A37 mRNA CTD PMID:30912803 Slc25a37 Rat valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of SLC25A37 mRNA CTD PMID:24136188 Slc25a37 Rat valproic acid increases expression ISO SLC25A37 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC25A37 mRNA CTD PMID:24935251 and PMID:29154799 Slc25a37 Rat vincristine decreases expression ISO SLC25A37 (Homo sapiens) 6480464 Vincristine results in decreased expression of SLC25A37 mRNA CTD PMID:23649840 Slc25a37 Rat zinc atom increases expression ISO SLC25A37 (Homo sapiens) 6480464 Zinc deficiency results in increased expression of SLC25A37 mRNA CTD PMID:18356318 Slc25a37 Rat zinc(0) increases expression ISO SLC25A37 (Homo sapiens) 6480464 Zinc deficiency results in increased expression of SLC25A37 mRNA CTD PMID:18356318
(-)-demecolcine (ISO) (1->4)-beta-D-glucan (ISO) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (EXP,ISO) 17beta-hydroxy-5alpha-androstan-3-one (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-butoxyethanol (ISO) 2-palmitoylglycerol (ISO) 3,3',5,5'-tetrabromobisphenol A (ISO) 3,4-methylenedioxymethamphetamine (ISO) 6-propyl-2-thiouracil (EXP) acrolein (ISO) aflatoxin B1 (ISO) Aflatoxin B2 alpha (ISO) all-trans-retinoic acid (ISO) alpha-pinene (ISO) anthracen-2-amine (EXP) aristolochic acid A (ISO) arsenous acid (ISO) atrazine (ISO) avobenzone (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) benzo[e]pyrene (ISO) bisphenol A (EXP,ISO) caffeine (EXP) carbon nanotube (ISO) cobalt dichloride (EXP,ISO) cocaine (ISO) copper atom (ISO) copper(0) (ISO) copper(II) sulfate (ISO) coumarin (ISO) coumestrol (ISO) crocidolite asbestos (ISO) cyclosporin A (ISO) cyproconazole (ISO) diarsenic trioxide (ISO) dibenz[a,h]anthracene (ISO) Dibutyl phosphate (ISO) dibutyl phthalate (ISO) disulfiram (ISO) dorsomorphin (ISO) elemental selenium (ISO) endosulfan (EXP) entinostat (ISO) epoxiconazole (ISO) ethanol (ISO) ethyl methanesulfonate (ISO) fluoranthene (ISO) flutamide (EXP) folic acid (ISO) FR900359 (ISO) gentamycin (EXP) heroin (ISO) inulin (ISO) manganese(II) chloride (EXP) metformin (ISO) methapyrilene (ISO) methoxyacetic acid (EXP) methyl methanesulfonate (ISO) methylmercury chloride (EXP) Monobutylphthalate (EXP) N-methyl-4-phenylpyridinium (EXP) nitrofen (EXP) oxaliplatin (EXP) ozone (ISO) paracetamol (ISO) perfluorooctane-1-sulfonic acid (ISO) phenobarbital (ISO) phosphane (EXP) pirinixic acid (ISO) potassium chromate (ISO) pregnenolone 16alpha-carbonitrile (ISO) propiconazole (ISO) resveratrol (ISO) rotenone (ISO) SB 431542 (ISO) selenium atom (ISO) serpentine asbestos (ISO) silicon dioxide (ISO) sodium arsenite (ISO) sunitinib (ISO) tamoxifen (ISO) testosterone (EXP) tetrachloromethane (EXP,ISO) titanium dioxide (ISO) topotecan (EXP) trimellitic anhydride (ISO) triphenyl phosphate (ISO) tungsten (ISO) valdecoxib (EXP) valproic acid (ISO) vincristine (ISO) zinc atom (ISO) zinc(0) (ISO)
Slc25a37 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 15 50,944,085 - 50,986,506 (-) NCBI GRCr8 mRatBN7.2 15 44,534,280 - 44,576,697 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 15 44,536,727 - 44,577,199 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 15 48,654,708 - 48,694,617 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 15 49,766,201 - 49,806,109 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 15 46,625,537 - 46,665,442 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 15 51,125,764 - 51,168,384 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 15 51,128,268 - 51,168,384 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 15 54,858,085 - 54,898,295 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 15 49,806,324 - 49,846,988 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 15 49,822,103 - 49,862,768 (-) NCBI Celera 15 44,219,968 - 44,259,652 (-) NCBI Celera Cytogenetic Map 15 p11 NCBI
SLC25A37 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 8 23,528,956 - 23,575,463 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 8 23,528,956 - 23,575,463 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 8 23,386,469 - 23,432,976 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 8 23,442,308 - 23,486,008 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 8 22,349,849 - 22,393,485 (+) NCBI Celera Cytogenetic Map 8 p21.2 NCBI HuRef 8 21,931,691 - 21,975,329 (+) NCBI HuRef CHM1_1 8 23,588,441 - 23,632,083 (+) NCBI CHM1_1 T2T-CHM13v2.0 8 23,803,825 - 23,850,325 (+) NCBI T2T-CHM13v2.0
Slc25a37 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 14 69,479,297 - 69,522,993 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 14 69,479,297 - 69,522,561 (-) Ensembl GRCm39 Ensembl GRCm38 14 69,241,848 - 69,285,544 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 14 69,241,848 - 69,285,112 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 14 69,859,908 - 69,903,160 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 14 68,195,181 - 68,238,433 (-) NCBI MGSCv36 mm8 Celera 14 67,022,482 - 67,064,035 (-) NCBI Celera Cytogenetic Map 14 D2 NCBI cM Map 14 36.03 NCBI
Slc25a37 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955403 46,697,560 - 46,739,903 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955403 46,697,560 - 46,739,082 (+) NCBI ChiLan1.0 ChiLan1.0
SLC25A37 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 7 42,033,353 - 42,079,997 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 8 17,760,577 - 17,807,224 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 8 22,778,309 - 22,824,871 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 8 19,713,441 - 19,759,994 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 8 19,713,441 - 19,759,993 (+) Ensembl panpan1.1 panPan2
SLC25A37 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 25 33,923,108 - 33,965,577 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 25 33,894,132 - 33,965,398 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 25 34,511,573 - 34,554,057 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 25 34,129,732 - 34,172,191 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 25 34,100,661 - 34,172,110 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 25 34,076,909 - 34,119,402 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 25 33,931,011 - 33,973,657 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 25 34,086,138 - 34,129,133 (-) NCBI UU_Cfam_GSD_1.0
Slc25a37 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404943 11,554,006 - 11,590,145 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936555 6,980,194 - 7,018,134 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936555 6,980,239 - 7,016,490 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
SLC25A37 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 14 7,665,007 - 7,706,768 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 14 7,665,002 - 7,709,998 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 14 8,517,481 - 8,695,604 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
SLC25A37 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 8 21,646,854 - 21,691,812 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 8 21,646,869 - 21,694,938 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666052 20,526,478 - 20,574,556 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Slc25a37 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 75 Count of miRNA genes: 59 Interacting mature miRNAs: 66 Transcripts: ENSRNOT00000021636 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1331729 Rf42 Renal function QTL 42 3.071 kidney blood vessel physiology trait (VT:0100012) absolute change in renal blood flow rate (CMO:0001168) 15 17362897 73690657 Rat 1582227 Gluco30 Glucose level QTL 30 3.6 0.0003 blood glucose amount (VT:0000188) absolute change in blood glucose level area under curve (CMO:0002034) 15 28030665 82262678 Rat 1582228 Epfw3 Epididymal fat weight QTL 3 4.1 0.0002 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 15 28030665 82262678 Rat 1578646 Bmd18 Bone mineral density QTL 18 5.2 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 15 22806240 98288169 Rat 1578647 Bmd17 Bone mineral density QTL 17 4 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 15 22806240 98288169 Rat 10401805 Kidm51 Kidney mass QTL 51 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 15 306329 45306329 Rat 2293686 Bmd36 Bone mineral density QTL 36 7.4 0.0001 femur strength trait (VT:0010010) femoral neck ultimate force (CMO:0001703) 15 33611058 71477291 Rat 2317750 Glom26 Glomerulus QTL 26 4.3 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 15 12496141 65205939 Rat 2298549 Neuinf12 Neuroinflammation QTL 12 3.5 nervous system integrity trait (VT:0010566) spinal cord beta-2 microglobulin mRNA level (CMO:0002125) 15 1 55302115 Rat 2293691 Bmd37 Bone mineral density QTL 37 6.6 0.0001 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 15 33611058 71477291 Rat 2293688 Bss29 Bone structure and strength QTL 29 5.31 0.0001 femur morphology trait (VT:0000559) femur midshaft cortical cross-sectional area (CMO:0001663) 15 11111142 56111142 Rat 1582214 Stl21 Serum triglyceride level QTL 21 3.1 0.022 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 15 28030665 82262678 Rat 631273 Lecl2 Lens clarity QTL 2 0.001 lens clarity trait (VT:0001304) age of onset/diagnosis of cataract (CMO:0001584) 15 10596089 55596089 Rat 1300144 Rf23 Renal function QTL 23 3.61 renal blood flow trait (VT:2000006) absolute change in renal vascular resistance (CMO:0001900) 15 40631268 98288169 Rat 2300167 Bmd63 Bone mineral density QTL 63 5.9 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 15 11111142 56111142 Rat 738017 Hcas7 Hepatocarcinoma susceptibility QTL 7 2.91 liver integrity trait (VT:0010547) liver nonremodeling tumorous lesion volume to total liver volume ratio (CMO:0001464) 15 2266368 46921453 Rat 152025253 Hrtrt24 Heart rate QTL 24 3.82 heart pumping trait (VT:2000009) 15 27885774 86257085 Rat 10054130 Srcrt8 Stress Responsive Cort QTL 8 2.18 0.0085 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 15 22117933 67117933 Rat 2300173 Bmd62 Bone mineral density QTL 62 12.8 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 15 11111142 56111142 Rat 2324620 Coatc3 Coat color QTL 3 coat/hair pigmentation trait (VT:0010463) pigmented coat/hair area to total coat/hair area ratio (CMO:0001810) 15 19856566 46187442 Rat 61424 Scl1 Serum cholesterol level QTL 1 7.7 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 15 16725528 80672115 Rat 1582251 Gluco24 Glucose level QTL 24 3.2 0.0008 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 15 5530756 50530756 Rat 1598828 Glom14 Glomerulus QTL 14 2.5 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 15 34054139 79054139 Rat 1582242 Gluco28 Glucose level QTL 28 3.3 0.0008 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 15 28030665 82262678 Rat 2306968 Anxrr23 Anxiety related response QTL 23 4.83 reflex trait (VT:0001961) amplitude of the acoustic startle response (CMO:0001520) 15 40631268 46187442 Rat 1578660 Bss19 Bone structure and strength QTL 19 4.3 femur morphology trait (VT:0000559) bone trabecular cross-sectional area (CMO:0002311) 15 22806240 98288169 Rat 1582244 Bw79 Body weight QTL 79 4 0.0002 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 15 28030665 82262678 Rat 7411725 Strs7 Sensitivity to stroke QTL 7 3.8 cerebrum integrity trait (VT:0010549) percentage of study population developing cerebrovascular lesions during a period of time (CMO:0000932) 15 40289901 49308583 Rat
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000021636 ⟹ ENSRNOP00000021636
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 15 44,536,727 - 44,577,199 (-) Ensembl Rnor_6.0 Ensembl 15 51,128,268 - 51,168,384 (-) Ensembl
RefSeq Acc Id:
NM_001013996 ⟹ NP_001014018
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 15 50,946,589 - 50,986,500 (-) NCBI mRatBN7.2 15 44,536,784 - 44,576,697 (-) NCBI Rnor_6.0 15 51,128,268 - 51,168,384 (-) NCBI Rnor_5.0 15 54,858,085 - 54,898,295 (-) NCBI RGSC_v3.4 15 49,806,324 - 49,846,988 (-) RGD Celera 15 44,219,968 - 44,259,652 (-) RGD
Sequence:
TGCTCGGCTCCACCCCAGCCCGCCATGGCGTCAGCCGCCGCAACCCGGGGGAGGAGGTTCCCACTTTAAGAAGTGAAGTTTTCCTCCCCCTCCCCCTCCTACCCACCTCCTGCCGCCTCCCGCGCCCC ACGGGGCCGCGGATGGAGCTCCGCCGTGGCGGCGTGGGGAGCCAGGCTGCCGGCCGGAGGATGGATGGGGACTGCCGCGATGGCGGCTGCGGCAGCAAGGACGCCGGGTCGGAGGACTATGAGAACCT ACCGACCAGTGCCTCGGTGTCCACCCACATGACAGCGGGAGCGATGGCCGGGATTCTGGAGCACTCCATCATGTACCCGGTGGACTCCGTGAAGACACGGATGCAGAGTTTGAACCCAGATCCCAAAG CCCGGTATACAAGCATCTATGGCGCCCTCAAGAGGATCATGCACACTGAAGGCTTCTGGAGGCCCCTGCGGGGCCTGAACGTGATGATGATGGGTGCGGGGCCTGCGCACGCCATGTATTTTGCCTGC TATGAAAACATGAAAAGGACTTTAAATGACGTTTTCAGCCACCAAGGAAACAGCCATCTAGCTAATGGGATAGCTGGGAGTATGGCCACCCTACTCCACGATGCAGTAATGAATCCAGCAGAAGTGGT GAAACAGCGATTGCAGATGTACAACTCACAGCACCAGTCAGCCCTCAGTTGTATCCGGACAGTGTGGAGGACCGAGGGGTTGGGGGCCTTCTACAGGAGTTACACCACACAGCTGACCATGAACATCC CCTTCCAATCTATCCACTTCATCACCTATGAGTTTCTGCAGGAGCAAGTCAACCCTCGCCGGGACTATAACCCACAGTCTCACATCATCTCAGGAGGCCTGGCCGGTGCGCTGGCTGCAGCTGCCACC ACCCCGCTGGATGTCTGCAAGACCCTCCTCAACACGCAGGAGAACATGGCACTCTCCCTAGCTAATGTCAGTGGCCGGCTGTCAGGCATGGCCAATGCCTTCCGGACGGTGTACCAGCTCAACGGCCT TGCTGGGTACTTCAAAGGCATTCAGGCTCGAGTCATCTACCAGATGCCTTCCACCGCCATCTCCTGGTCTGTTTATGAGTTCTTCAAGTATTTCCTTACGAAGCGGCAGCTGGAGAATCGAACTCTGT ACTAAAGGAACAGGGCAGTGGGAAGTGGTTCCGGCATCTTTTGTTCCAGCTCCATGCTCCTGTCCTTGCACCCAGGTCTTGTCCTGAAGGGTGCTTGCGCCGGGTCCTTCGTTCCCTGGTGCCTTGGA AAGGGAGGACCAGCCTCCACTGACCAGCATGCTGTCTGAGGGGACATCCGAGGTGGTGGTAGGCAGGAGAAACTCAGGGAGAGGGAGAAGTTGCTTTTTCTCCTCCTTCCCCGAGAGGAATGTAGCTT TTCTGCCTCACTGTGGCCTTCTCACTAGATCTTTAGATCGCACCGAAGAGGCAAACAGTGACACAGTAAAGAAAAAGTTTATGTACATAAAAGTACCATTACCCAGTCTGAAATAGGTGGATAATGTT TATCCTTTATTTTTCTACATAGAGATTTTTGAAATTGTGAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_006252266 ⟹ XP_006252328
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 15 50,944,085 - 50,986,479 (-) NCBI mRatBN7.2 15 44,534,280 - 44,576,656 (-) NCBI Rnor_6.0 15 51,125,764 - 51,168,377 (-) NCBI Rnor_5.0 15 54,858,085 - 54,898,295 (-) NCBI
Sequence:
CTCCACCCCAGCCCGCCATGGCGTCAGCCGCCGCAACCCGGGGGAGGAGGTTCCCACTTTAAGAAGTGAAGTTTTCCTCCCCCTCCCCCTCCTACCCACCTCCTGCCGCCTCCCGCGCCCCACGGGGC CGCGGATGGAGCTCCGCCGTGGCGGCGTGGGGAGCCAGGCTGCCGGCCGGAGGATGGATGGGGACTGCCGCGATGGCGGCTGCGGCAGCAAGGACGCCGGGTCGGAGGACTATGAGAACCTACCGACC AGTGCCTCGGTGTCCACCCACATGACAGCGGGAGCGATGGCCGGGATTCTGGAGCACTCCATCATGTACCCGGTGGACTCCGTGAAGGTGTTTCAAGTCTCTCCTACTGAGGTGATAAGCAAGACTCT CCAGAGGAAAAGACCAAGAAGGACACGGATGCAGAGTTTGAACCCAGATCCCAAAGCCCGGTATACAAGCATCTATGGCGCCCTCAAGAGGATCATGCACACTGAAGGCTTCTGGAGGCCCCTGCGGG GCCTGAACGTGATGATGATGGGTGCGGGGCCTGCGCACGCCATGTATTTTGCCTGCTATGAAAACATGAAAAGGACTTTAAATGACGTTTTCAGCCACCAAGGAAACAGCCATCTAGCTAATGGGATA GCTGGGAGTATGGCCACCCTACTCCACGATGCAGTAATGAATCCAGCAGAAGTGGTGAAACAGCGATTGCAGATGTACAACTCACAGCACCAGTCAGCCCTCAGTTGTATCCGGACAGTGTGGAGGAC CGAGGGGTTGGGGGCCTTCTACAGGAGTTACACCACACAGCTGACCATGAACATCCCCTTCCAATCTATCCACTTCATCACCTATGAGTTTCTGCAGGAGCAAGTCAACCCTCGCCGGGACTATAACC CACAGTCTCACATCATCTCAGGAGGCCTGGCCGGTGCGCTGGCTGCAGCTGCCACCACCCCGCTGGATGTCTGCAAGACCCTCCTCAACACGCAGGAGAACATGGCACTCTCCCTAGCTAATGTCAGT GGCCGGCTGTCAGGCATGGCCAATGCCTTCCGGACGGTGTACCAGCTCAACGGCCTTGCTGGGTACTTCAAAGGCATTCAGGCTCGAGTCATCTACCAGATGCCTTCCACCGCCATCTCCTGGTCTGT TTATGAGTTCTTCAAGTATTTCCTTACGAAGCGGCAGCTGGAGAATCGAACTCTGTACTAAAGGAACAGGGCAGTGGGAAGTGGTTCCGGCATCTTTTGTTCCAGCTCCATGCTCCTGTCCTTGCACC CAGGTCTTGTCCTGAAGGGTGCTTGCGCCGGGTCCTTCGTTCCCTGGTGCCTTGGAAAGGGAGGACCAGCCTCCACTGACCAGCATGCTGTCTGAGGGGACATCCGAGGTGGTGGTAGGCAGGAGAAA CTCAGGGAGAGGGAGAAGTTGCTTTTTCTCCTCCTTCCCCGAGAGGAATGTAGCTTTTCTGCCTCACTGTGGCCTTCTCACTAGATCTTTAGATCGCACCGAAGAGGCAAACAGTGACACAGTAAAGA AAAAGTTTATGTACATAAAAGTACCATTACCCAGTCTGAAATAGGTGGATAATGTTTATCCTTTATTTTTCTACATAGAGATTTTTGAAATTGTGTGTGCTTGTGTGTGTCCATAAATAGTATTAGAG TTGGGAATGATGGGCCTGCTTTTTAAAAAAAGAAAAAAATAAGAGAGTTGAATTCTTCCTTCATGAGAAGTAAAACAAACAACAACAACAAAACCCCCAAGGAATAAAAGTAATAAATGGCTTTATGT GGCCTGAAATTGTGTGTAGTCCCCTCCTGTGGGAGTTTAACTTGAATGTAAAATAATAAATACAAAGTTTATGTTTTGAATTTCTCTTTTCATGGGGAAAAAGGTACGTTGCAAACAAATCAAAATAG TCTTATCACTTGGAGCTTTTTTTTTTCTTTTTAAGTAGTCACCCCGAGTGCCTTTCTGTCTTTTCTAAGACTTCCGGGACCAAAAATGGGGTCCTAGAGCACCTTCCTCCCTCTGTGGACTCCCCCAT TCAGATCTCAGCAGCCTGGTTGTCACAGTAGAATAAGAATGGCTGGCCTTAACCTTCCCTGTGAGTGACGTGAATGAATGCCTACCTGGCTAGCTCTTAGCACTAGAGATGCCACCGTCTGCCTAGCG AGTCCATGAGACAGTTCCTGCCTTTGTCTTAGGACTAATTTCTGCAGCAACCTCCTTCCTGGGCACTTCTGCTAACCTGGCCTATAAGTCTTTTTATTAGCCCCCTCTTGACCCATTTCCCCTGCAGT CTAGGGATTTTGAGTATCTCTGGCACTCATCTGTCTCCTGCCCTGTTCCAGCTCTGTGACTTTAGCATCATAGCCTCTTACTGCACTGAGGCTAGCCCTCCAGCTCTGTGACTTTAGCATCATAGCCT CTTACTGCACTGAGGCTAGCCCTCCAGCTGAGACTGAAGCACGCTCTGACCCTCTGCCCCTCCAGAGCTGCTCAGCAGCCTTGTGTCTTCTACATCCTCTCTGCTTTGTTTTCTGAAGTACAGTCAGA TCATCTCTGAGAAAACACAAGCCTGTGTTGTCCAGTCTCCCATCTTCACAGAGATGAGAGGATTGTCTCAGTTTCCCTCTTCTGACTGTCTATTAGGAAGCAGGGCTTGCTTTTCCCTGGCCCTGTTT TCATTTGGAAGCCATGGTTAGCATGCTTCCTCACTGGAAGCTTAGACCTTGAATTCCCATGGAACGTCATACTGCCTGGGAAGAAATTCAGCTTGTACTTGGAGAATTTTCACCTTTGGGACCATGTA CCATCCAGTGCCCATGGATGCGGGTTTTTGGTTTTGTTCAGGCTGTGAGAAGTTACACGCTGGTCAGCTGACTTTTCTTTTCTGAGAGAATCACCTCTCAAATGCTTTCCTGTGCTCCCTGAGGGCCT CCTGGCTGGTTGCAGGTTTCTGTTTTACTGGTGTTCTGGGCTGGCTGGTGTCCTGTTATCACTTGATAGAAAGAATAGAAAATGTTTCTACTCTTACCCTGCTAGCGTTGAGTAGTGTTAAATCCTAT ACATGGAGAGGGGAAGTCAAATTGTAGAGTCTAAAGTAAACTTTAAGTCAAACCCTAAACTGTCCCCACACCACCCTTTGATACACGGGTGGCTAATCCTGCTGCAAAAACAAGACTTCTCTTTGGAT TTTCTTTACAGCTATCTAATACTTGGCTAGTCTCTTTGCTTAGGGCCTTTTAAGGTAGGATCAGGACTTCAGGACTCTGTGGGGTTGAAGTCCAGGGGTCCTGTTCTGGCTATGCCCTCCCCATGATG ATTGGTGGGTCTGCAGGAGGACAGCTTTTTAACCTGTGCCTCCCGTCCAGTCACCCTAAGATTGAGCAAGGGATGTGTCTGTGGAAAAAGTTAAAAGTTGGGAAGCAATCAACAAGAGTTCTGTGGTA GCCAGTACCCCCACTCCTTAGTTCCACAGTTGGAATTCTCCTTGACCTCATCACATTTTAGCCTGTGTGTTGATTGTAATTTTTGACATTGTAAATTTCTAGATAGGAAAATGCTTCCCCTGCCCAGT GACCAGATTAGGAGAGCCATAACCTGGGTACAATGATAATACTTTGACCTGTGTGTGTGTGTATATATATGGTGTGTATGTGTGTATATGTGTGTTCAGGTTATGTGGCAGCCAACCATATTAAATGA GTGTTAATTTATTATAGACAAATATTGATCTTTTTAAAATGGGATGCTCTTAATTCTTGAGTTTTTAAAGAATTTGATTAAATAGAGCTACTTTTACATGAGCTTGGTCCCCTCTGTCCCCTCTATCT CATGTCTTAGAACCATCACCCTCCAATGTCACCCCAGTGCTTTATCTCCAACATACTGCTATGCCACTAAGGTTTTATTTAACTTTATTTATGGATATGTGTCTGTGAACAACAACTGTGCCACTGCT GGGTTGCACAGTGTGTGGGCTAAGAGTGGCCCAATGTTGCTTTTTGAATGTCTTAAAATGCGGCTTTTGGGTCTGGGGAGCAGTGGTGTGTTCACATGTGTGGGTGTCTGGTGTGCTGCTACAGTTGT AACACTGGAGCTGGAGAAAATAAAGAATCGATCCTGAAA
hide sequence
RefSeq Acc Id:
XM_017599697 ⟹ XP_017455186
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 15 50,944,085 - 50,954,326 (-) NCBI mRatBN7.2 15 44,534,280 - 44,544,503 (-) NCBI Rnor_6.0 15 51,125,764 - 51,136,007 (-) NCBI
Sequence:
GAACACGGAGAGGCATCCTTCCTACCTGTTTCTATGCGGTGCTGAGGACTGAATCTAGTACATG CTGGACAGACACGGATGCAGAGTTTGAACCCAGATCCCAAAGCCCGGTATACAAGCATCTATGGCGCCCTCAAGAGGATCATGCACACTGAAGGCTTCTGGAGGCCCCTGCGGGGCCTGAACGTGATG ATGATGGGTGCGGGGCCTGCGCACGCCATGTATTTTGCCTGCTATGAAAACATGAAAAGGACTTTAAATGACGTTTTCAGCCACCAAGGAAACAGCCATCTAGCTAATGGGATAGCTGGGAGTATGGC CACCCTACTCCACGATGCAGTAATGAATCCAGCAGAAGTGGTGAAACAGCGATTGCAGATGTACAACTCACAGCACCAGTCAGCCCTCAGTTGTATCCGGACAGTGTGGAGGACCGAGGGGTTGGGGG CCTTCTACAGGAGTTACACCACACAGCTGACCATGAACATCCCCTTCCAATCTATCCACTTCATCACCTATGAGTTTCTGCAGGAGCAAGTCAACCCTCGCCGGGACTATAACCCACAGTCTCACATC ATCTCAGGAGGCCTGGCCGGTGCGCTGGCTGCAGCTGCCACCACCCCGCTGGATGTCTGCAAGACCCTCCTCAACACGCAGGAGAACATGGCACTCTCCCTAGCTAATGTCAGTGGCCGGCTGTCAGG CATGGCCAATGCCTTCCGGACGGTGTACCAGCTCAACGGCCTTGCTGGGTACTTCAAAGGCATTCAGGCTCGAGTCATCTACCAGATGCCTTCCACCGCCATCTCCTGGTCTGTTTATGAGTTCTTCA AGTATTTCCTTACGAAGCGGCAGCTGGAGAATCGAACTCTGTACTAAAGGAACAGGGCAGTGGGAAGTGGTTCCGGCATCTTTTGTTCCAGCTCCATGCTCCTGTCCTTGCACCCAGGTCTTGTCCTG AAGGGTGCTTGCGCCGGGTCCTTCGTTCCCTGGTGCCTTGGAAAGGGAGGACCAGCCTCCACTGACCAGCATGCTGTCTGAGGGGACATCCGAGGTGGTGGTAGGCAGGAGAAACTCAGGGAGAGGGA GAAGTTGCTTTTTCTCCTCCTTCCCCGAGAGGAATGTAGCTTTTCTGCCTCACTGTGGCCTTCTCACTAGATCTTTAGATCGCACCGAAGAGGCAAACAGTGACACAGTAAAGAAAAAGTTTATGTAC ATAAAAGTACCATTACCCAGTCTGAAATAGGTGGATAATGTTTATCCTTTATTTTTCTACATAGAGATTTTTGAAATTGTGTGTGCTTGTGTGTGTCCATAAATAGTATTAGAGTTGGGAATGATGGG CCTGCTTTTTAAAAAAAGAAAAAAATAAGAGAGTTGAATTCTTCCTTCATGAGAAGTAAAACAAACAACAACAACAAAACCCCCAAGGAATAAAAGTAATAAATGGCTTTATGTGGCCTGAAATTGTG TGTAGTCCCCTCCTGTGGGAGTTTAACTTGAATGTAAAATAATAAATACAAAGTTTATGTTTTGAATTTCTCTTTTCATGGGGAAAAAGGTACGTTGCAAACAAATCAAAATAGTCTTATCACTTGGA GCTTTTTTTTTTCTTTTTAAGTAGTCACCCCGAGTGCCTTTCTGTCTTTTCTAAGACTTCCGGGACCAAAAATGGGGTCCTAGAGCACCTTCCTCCCTCTGTGGACTCCCCCATTCAGATCTCAGCAG CCTGGTTGTCACAGTAGAATAAGAATGGCTGGCCTTAACCTTCCCTGTGAGTGACGTGAATGAATGCCTACCTGGCTAGCTCTTAGCACTAGAGATGCCACCGTCTGCCTAGCGAGTCCATGAGACAG TTCCTGCCTTTGTCTTAGGACTAATTTCTGCAGCAACCTCCTTCCTGGGCACTTCTGCTAACCTGGCCTATAAGTCTTTTTATTAGCCCCCTCTTGACCCATTTCCCCTGCAGTCTAGGGATTTTGAG TATCTCTGGCACTCATCTGTCTCCTGCCCTGTTCCAGCTCTGTGACTTTAGCATCATAGCCTCTTACTGCACTGAGGCTAGCCCTCCAGCTCTGTGACTTTAGCATCATAGCCTCTTACTGCACTGAG GCTAGCCCTCCAGCTGAGACTGAAGCACGCTCTGACCCTCTGCCCCTCCAGAGCTGCTCAGCAGCCTTGTGTCTTCTACATCCTCTCTGCTTTGTTTTCTGAAGTACAGTCAGATCATCTCTGAGAAA ACACAAGCCTGTGTTGTCCAGTCTCCCATCTTCACAGAGATGAGAGGATTGTCTCAGTTTCCCTCTTCTGACTGTCTATTAGGAAGCAGGGCTTGCTTTTCCCTGGCCCTGTTTTCATTTGGAAGCCA TGGTTAGCATGCTTCCTCACTGGAAGCTTAGACCTTGAATTCCCATGGAACGTCATACTGCCTGGGAAGAAATTCAGCTTGTACTTGGAGAATTTTCACCTTTGGGACCATGTACCATCCAGTGCCCA TGGATGCGGGTTTTTGGTTTTGTTCAGGCTGTGAGAAGTTACACGCTGGTCAGCTGACTTTTCTTTTCTGAGAGAATCACCTCTCAAATGCTTTCCTGTGCTCCCTGAGGGCCTCCTGGCTGGTTGCA GGTTTCTGTTTTACTGGTGTTCTGGGCTGGCTGGTGTCCTGTTATCACTTGATAGAAAGAATAGAAAATGTTTCTACTCTTACCCTGCTAGCGTTGAGTAGTGTTAAATCCTATACATGGAGAGGGGA AGTCAAATTGTAGAGTCTAAAGTAAACTTTAAGTCAAACCCTAAACTGTCCCCACACCACCCTTTGATACACGGGTGGCTAATCCTGCTGCAAAAACAAGACTTCTCTTTGGATTTTCTTTACAGCTA TCTAATACTTGGCTAGTCTCTTTGCTTAGGGCCTTTTAAGGTAGGATCAGGACTTCAGGACTCTGTGGGGTTGAAGTCCAGGGGTCCTGTTCTGGCTATGCCCTCCCCATGATGATTGGTGGGTCTGC AGGAGGACAGCTTTTTAACCTGTGCCTCCCGTCCAGTCACCCTAAGATTGAGCAAGGGATGTGTCTGTGGAAAAAGTTAAAAGTTGGGAAGCAATCAACAAGAGTTCTGTGGTAGCCAGTACCCCCAC TCCTTAGTTCCACAGTTGGAATTCTCCTTGACCTCATCACATTTTAGCCTGTGTGTTGATTGTAATTTTTGACATTGTAAATTTCTAGATAGGAAAATGCTTCCCCTGCCCAGTGACCAGATTAGGAG AGCCATAACCTGGGTACAATGATAATACTTTGACCTGTGTGTGTGTGTATATATATGGTGTGTATGTGTGTATATGTGTGTTCAGGTTATGTGGCAGCCAACCATATTAAATGAGTGTTAATTTATTA TAGACAAATATTGATCTTTTTAAAATGGGATGCTCTTAATTCTTGAGTTTTTAAAGAATTTGATTAAATAGAGCTACTTTTACATGAGCTTGGTCCCCTCTGTCCCCTCTATCTCATGTCTTAGAACC ATCACCCTCCAATGTCACCCCAGTGCTTTATCTCCAACATACTGCTATGCCACTAAGGTTTTATTTAACTTTATTTATGGATATGTGTCTGTGAACAACAACTGTGCCACTGCTGGGTTGCACAGTGT GTGGGCTAAGAGTGGCCCAATGTTGCTTTTTGAATGTCTTAAAATGCGGCTTTTGGGTCTGGGGAGCAGTGGTGTGTTCACATGTGTGGGTGTCTGGTGTGCTGCTACAGTTGTAACACTGGAGCTGG AGAAAATAAAGAATCGATCCTGAAA
hide sequence
RefSeq Acc Id:
XM_017599698 ⟹ XP_017455187
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 15 50,944,085 - 50,951,348 (-) NCBI mRatBN7.2 15 44,534,280 - 44,541,728 (-) NCBI Rnor_6.0 15 51,125,764 - 51,133,223 (-) NCBI
Sequence:
TGAAAGTGTTTGTCTGGAGCTGGGAAGCTCTTCAGTGCTTGCTCCCTGGGGCTTCTTCCCCGGG ACCCAGCAGCCTTCTTCCTCGGCTGTTTGCTCAGGAACAGAGGACTCTAGGGTCACTTGAATGTGCACACACGTTTTTATTCAATCCCTCTTTCTCTGGGGGAAGCTGGTGGTAGATGTGTTTTGATA TTTGGTATTTATTATTGTGTGGCCTTTTTCTTTTCTTTTCTTTTTTTTTTTTTAAACACTCAACAATTAATGATCAGTCATAGGAAAAAATTTCTTTTGAATGCTGGATGCAAAACAAAATACAGAAA AGGACAGCTTCTTTGAGACTATTTAAAAACTGGTACAGCAGGTATCTCCAGCACCAGGATCTAACTAAACTTTGAAAGGTCAAGACGGTTTATGCTGACAGAGGACTCCGAGCCACTGTGGAAGGCCA TCCCCACTTTAAGCTTCAGGAGATTCGGGCCTTTGATCCCCCCAGCCTCCTCTGGATAGCTGGGAGTATGGCCACCCTACTCCACGATGCAGTAATGAATCCAGCAGAAGTGGTGAAACAGCGATTGC AGATGTACAACTCACAGCACCAGTCAGCCCTCAGTTGTATCCGGACAGTGTGGAGGACCGAGGGGTTGGGGGCCTTCTACAGGAGTTACACCACACAGCTGACCATGAACATCCCCTTCCAATCTATC CACTTCATCACCTATGAGTTTCTGCAGGAGCAAGTCAACCCTCGCCGGGACTATAACCCACAGTCTCACATCATCTCAGGAGGCCTGGCCGGTGCGCTGGCTGCAGCTGCCACCACCCCGCTGGATGT CTGCAAGACCCTCCTCAACACGCAGGAGAACATGGCACTCTCCCTAGCTAATGTCAGTGGCCGGCTGTCAGGCATGGCCAATGCCTTCCGGACGGTGTACCAGCTCAACGGCCTTGCTGGGTACTTCA AAGGCATTCAGGCTCGAGTCATCTACCAGATGCCTTCCACCGCCATCTCCTGGTCTGTTTATGAGTTCTTCAAGTATTTCCTTACGAAGCGGCAGCTGGAGAATCGAACTCTGTACTAAAGGAACAGG GCAGTGGGAAGTGGTTCCGGCATCTTTTGTTCCAGCTCCATGCTCCTGTCCTTGCACCCAGGTCTTGTCCTGAAGGGTGCTTGCGCCGGGTCCTTCGTTCCCTGGTGCCTTGGAAAGGGAGGACCAGC CTCCACTGACCAGCATGCTGTCTGAGGGGACATCCGAGGTGGTGGTAGGCAGGAGAAACTCAGGGAGAGGGAGAAGTTGCTTTTTCTCCTCCTTCCCCGAGAGGAATGTAGCTTTTCTGCCTCACTGT GGCCTTCTCACTAGATCTTTAGATCGCACCGAAGAGGCAAACAGTGACACAGTAAAGAAAAAGTTTATGTACATAAAAGTACCATTACCCAGTCTGAAATAGGTGGATAATGTTTATCCTTTATTTTT CTACATAGAGATTTTTGAAATTGTGTGTGCTTGTGTGTGTCCATAAATAGTATTAGAGTTGGGAATGATGGGCCTGCTTTTTAAAAAAAGAAAAAAATAAGAGAGTTGAATTCTTCCTTCATGAGAAG TAAAACAAACAACAACAACAAAACCCCCAAGGAATAAAAGTAATAAATGGCTTTATGTGGCCTGAAATTGTGTGTAGTCCCCTCCTGTGGGAGTTTAACTTGAATGTAAAATAATAAATACAAAGTTT ATGTTTTGAATTTCTCTTTTCATGGGGAAAAAGGTACGTTGCAAACAAATCAAAATAGTCTTATCACTTGGAGCTTTTTTTTTTCTTTTTAAGTAGTCACCCCGAGTGCCTTTCTGTCTTTTCTAAGA CTTCCGGGACCAAAAATGGGGTCCTAGAGCACCTTCCTCCCTCTGTGGACTCCCCCATTCAGATCTCAGCAGCCTGGTTGTCACAGTAGAATAAGAATGGCTGGCCTTAACCTTCCCTGTGAGTGACG TGAATGAATGCCTACCTGGCTAGCTCTTAGCACTAGAGATGCCACCGTCTGCCTAGCGAGTCCATGAGACAGTTCCTGCCTTTGTCTTAGGACTAATTTCTGCAGCAACCTCCTTCCTGGGCACTTCT GCTAACCTGGCCTATAAGTCTTTTTATTAGCCCCCTCTTGACCCATTTCCCCTGCAGTCTAGGGATTTTGAGTATCTCTGGCACTCATCTGTCTCCTGCCCTGTTCCAGCTCTGTGACTTTAGCATCA TAGCCTCTTACTGCACTGAGGCTAGCCCTCCAGCTCTGTGACTTTAGCATCATAGCCTCTTACTGCACTGAGGCTAGCCCTCCAGCTGAGACTGAAGCACGCTCTGACCCTCTGCCCCTCCAGAGCTG CTCAGCAGCCTTGTGTCTTCTACATCCTCTCTGCTTTGTTTTCTGAAGTACAGTCAGATCATCTCTGAGAAAACACAAGCCTGTGTTGTCCAGTCTCCCATCTTCACAGAGATGAGAGGATTGTCTCA GTTTCCCTCTTCTGACTGTCTATTAGGAAGCAGGGCTTGCTTTTCCCTGGCCCTGTTTTCATTTGGAAGCCATGGTTAGCATGCTTCCTCACTGGAAGCTTAGACCTTGAATTCCCATGGAACGTCAT ACTGCCTGGGAAGAAATTCAGCTTGTACTTGGAGAATTTTCACCTTTGGGACCATGTACCATCCAGTGCCCATGGATGCGGGTTTTTGGTTTTGTTCAGGCTGTGAGAAGTTACACGCTGGTCAGCTG ACTTTTCTTTTCTGAGAGAATCACCTCTCAAATGCTTTCCTGTGCTCCCTGAGGGCCTCCTGGCTGGTTGCAGGTTTCTGTTTTACTGGTGTTCTGGGCTGGCTGGTGTCCTGTTATCACTTGATAGA AAGAATAGAAAATGTTTCTACTCTTACCCTGCTAGCGTTGAGTAGTGTTAAATCCTATACATGGAGAGGGGAAGTCAAATTGTAGAGTCTAAAGTAAACTTTAAGTCAAACCCTAAACTGTCCCCACA CCACCCTTTGATACACGGGTGGCTAATCCTGCTGCAAAAACAAGACTTCTCTTTGGATTTTCTTTACAGCTATCTAATACTTGGCTAGTCTCTTTGCTTAGGGCCTTTTAAGGTAGGATCAGGACTTC AGGACTCTGTGGGGTTGAAGTCCAGGGGTCCTGTTCTGGCTATGCCCTCCCCATGATGATTGGTGGGTCTGCAGGAGGACAGCTTTTTAACCTGTGCCTCCCGTCCAGTCACCCTAAGATTGAGCAAG GGATGTGTCTGTGGAAAAAGTTAAAAGTTGGGAAGCAATCAACAAGAGTTCTGTGGTAGCCAGTACCCCCACTCCTTAGTTCCACAGTTGGAATTCTCCTTGACCTCATCACATTTTAGCCTGTGTGT TGATTGTAATTTTTGACATTGTAAATTTCTAGATAGGAAAATGCTTCCCCTGCCCAGTGACCAGATTAGGAGAGCCATAACCTGGGTACAATGATAATACTTTGACCTGTGTGTGTGTGTATATATAT GGTGTGTATGTGTGTATATGTGTGTTCAGGTTATGTGGCAGCCAACCATATTAAATGAGTGTTAATTTATTATAGACAAATATTGATCTTTTTAAAATGGGATGCTCTTAATTCTTGAGTTTTTAAAG AATTTGATTAAATAGAGCTACTTTTACATGAGCTTGGTCCCCTCTGTCCCCTCTATCTCATGTCTTAGAACCATCACCCTCCAATGTCACCCCAGTGCTTTATCTCCAACATACTGCTATGCCACTAA GGTTTTATTTAACTTTATTTATGGATATGTGTCTGTGAACAACAACTGTGCCACTGCTGGGTTGCACAGTGTGTGGGCTAAGAGTGGCCCAATGTTGCTTTTTGAATGTCTTAAAATGCGGCTTTTGG GTCTGGGGAGCAGTGGTGTGTTCACATGTGTGGGTGTCTGGTGTGCTGCTACAGTTGTAACACTGGAGCTGGAGAAAATAAAGAATCGATCCTGAAA
hide sequence
RefSeq Acc Id:
XM_063274297 ⟹ XP_063130367
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 15 50,946,348 - 50,986,506 (-) NCBI
RefSeq Acc Id:
NP_001014018 ⟸ NM_001013996
- UniProtKB:
Q66H23 (UniProtKB/Swiss-Prot), A6HTH0 (UniProtKB/TrEMBL), A0A8L2QC12 (UniProtKB/TrEMBL)
- Sequence:
MELRRGGVGSQAAGRRMDGDCRDGGCGSKDAGSEDYENLPTSASVSTHMTAGAMAGILEHSIMYPVDSVKTRMQSLNPDPKARYTSIYGALKRIMHTEGFWRPLRGLNVMMMGAGPAHAMYFACYENM KRTLNDVFSHQGNSHLANGIAGSMATLLHDAVMNPAEVVKQRLQMYNSQHQSALSCIRTVWRTEGLGAFYRSYTTQLTMNIPFQSIHFITYEFLQEQVNPRRDYNPQSHIISGGLAGALAAAATTPLD VCKTLLNTQENMALSLANVSGRLSGMANAFRTVYQLNGLAGYFKGIQARVIYQMPSTAISWSVYEFFKYFLTKRQLENRTLY
hide sequence
RefSeq Acc Id:
XP_006252328 ⟸ XM_006252266
- Peptide Label:
isoform X1
- UniProtKB:
A0A8L2QC12 (UniProtKB/TrEMBL)
- Sequence:
MELRRGGVGSQAAGRRMDGDCRDGGCGSKDAGSEDYENLPTSASVSTHMTAGAMAGILEHSIMYPVDSVKVFQVSPTEVISKTLQRKRPRRTRMQSLNPDPKARYTSIYGALKRIMHTEGFWRPLRGL NVMMMGAGPAHAMYFACYENMKRTLNDVFSHQGNSHLANGIAGSMATLLHDAVMNPAEVVKQRLQMYNSQHQSALSCIRTVWRTEGLGAFYRSYTTQLTMNIPFQSIHFITYEFLQEQVNPRRDYNPQ SHIISGGLAGALAAAATTPLDVCKTLLNTQENMALSLANVSGRLSGMANAFRTVYQLNGLAGYFKGIQARVIYQMPSTAISWSVYEFFKYFLTKRQLENRTLY
hide sequence
RefSeq Acc Id:
XP_017455186 ⟸ XM_017599697
- Peptide Label:
isoform X3
- Sequence:
MQSLNPDPKARYTSIYGALKRIMHTEGFWRPLRGLNVMMMGAGPAHAMYFACYENMKRTLNDVFSHQGNSHLANGIAGSMATLLHDAVMNPAEVVKQRLQMYNSQHQSALSCIRTVWRTEGLGAFYRS YTTQLTMNIPFQSIHFITYEFLQEQVNPRRDYNPQSHIISGGLAGALAAAATTPLDVCKTLLNTQENMALSLANVSGRLSGMANAFRTVYQLNGLAGYFKGIQARVIYQMPSTAISWSVYEFFKYFLT KRQLENRTLY
hide sequence
RefSeq Acc Id:
XP_017455187 ⟸ XM_017599698
- Peptide Label:
isoform X4
- Sequence:
MATLLHDAVMNPAEVVKQRLQMYNSQHQSALSCIRTVWRTEGLGAFYRSYTTQLTMNIPFQSIH FITYEFLQEQVNPRRDYNPQSHIISGGLAGALAAAATTPLDVCKTLLNTQENMALSLANVSGRLSGMANAFRTVYQLNGLAGYFKGIQARVIYQMPSTAISWSVYEFFKYFLTKRQLENRTLY
hide sequence
Ensembl Acc Id:
ENSRNOP00000021636 ⟸ ENSRNOT00000021636
RefSeq Acc Id:
XP_063130367 ⟸ XM_063274297
- Peptide Label:
isoform X2
RGD ID: 13699797
Promoter ID: EPDNEW_R10320
Type: single initiation site
Name: Slc25a37_1
Description: solute carrier family 25 member 37
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 15 51,168,289 - 51,168,349 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-02-24
Slc25a37
solute carrier family 25 member 37
Slc25a37
solute carrier family 25 (mitochondrial iron transporter), member 37
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2012-10-16
Slc25a37
solute carrier family 25 (mitochondrial iron transporter), member 37
Slc25a37
solute carrier family 25, member 37
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-03-07
Slc25a37
solute carrier family 25, member 37
RGD1359361
mitochondrial carrier domain containing protein RGD1359361
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2005-11-17
RGD1359361
mitochondrial carrier domain containing protein RGD1359361
LOC306000
similar to mitochondrial solute carrier-like protein
Symbol and Name updated
1299863
APPROVED
2005-07-29
LOC306000
similar to mitochondrial solute carrier-like protein
Symbol and Name status set to provisional
70820
PROVISIONAL